BDBM510841 4-({(aR)-6-[7- cyclopropyl-6-(2- hydroxy-2- methylpropoxy)pyrazolo [1,5-a]pyridine-3- amido]spiro[3.3] heptan-2-yl}oxy)-2- phenyl-1,3-thiazole- 5-carboxamide::US11078197, Example 18::US11673886, Example 18

SMILES CC(C)(O)COc1ccc2c(C(=O)N[C@H]3CC4(C3)C[C@H](Oc3nc(-c5ccccc5)sc3C(N)=O)C4)cnn2c1C1CC1

InChI Key InChIKey=ZJOQTWWFIZMXMI-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 510841   

TargetRho-associated protein kinase 2(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 510841BDBM510841(4-({(aR)-6-[7- cyclopropyl-6-(2- hydroxy-2- methyl...)
Affinity DataIC50: 13.4nMAssay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL assay containing 20 mM HEPES, pH 7.5, 20...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2023
Entry Details
US Patent

TargetRho-associated protein kinase 2(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 510841BDBM510841(4-({(aR)-6-[7- cyclopropyl-6-(2- hydroxy-2- methyl...)
Affinity DataIC50: 1.34E+4nMAssay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL assay containing 20 mM HEPES, pH 7.5, 20...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/16/2022
Entry Details
US Patent